Highly sensitive C-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event

被引:9
作者
Monteiro, C. M. C. [1 ]
Pinheiro, L. F. [1 ]
Izar, M. C. [1 ]
Barros, S. W. [1 ]
Vasco, M. B. [1 ]
Fischer, S. M. [1 ]
Povoa, R. M. [1 ]
Brandao, S. A. [1 ]
Santos, A. O. [1 ]
Oliveira, L. [1 ]
Carvalho, A. C. [1 ]
Fonseca, F. A. H. [1 ]
机构
[1] Univ Fed Sao Paulo, EPM, Dept Med, Setor Lipides Aterosclerose & Biol Vasc,Disciplin, BR-04039030 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Metabolic syndrome; Acute coronary syndrome; C-reactive protein; Gender; Gensini score; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; HEART-DISEASE; CAROTID ATHEROSCLEROSIS; INSULIN-RESISTANCE; RISK-FACTORS; ALL-CAUSE; MORTALITY; ROSUVASTATIN; PROGRESSION;
D O I
10.1590/S0100-879X2010005000008
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Patients with metabolic syndrome are at high-risk for development of atherosclerosis and cardiovascular events. The objective of this study was to examine the major determinants of coronary disease severity, including those coronary risk factors associated with metabolic syndrome, during the early period after an acute coronary episode. We tested the hypothesis that inflammatory markers, especially highly sensitive C-reactive protein (hsCRP), are related to coronary atherosclerosis, in addition to traditional coronary risk factors. Subjects of both genders aged 30 to 75 years (N = 116) were prospectively included if they had suffered a recent acute coronary syndrome (acute myocardial infarction or unstable angina pectoris requiring hospitalization) and if they had metabolic syndrome diagnosed according to the National Cholesterol Education Program/Adult Treatment Panel III. Patients were submitted to a coronary angiography and the burden of atherosclerosis was estimated by the Gensini score. The severity of coronary disease was correlated (Spearman's or Pearson's coefficient) with gender (r = 0.291, P = 0.008), age (r = 0.218, P = 0.048), hsCRP (r = 0.256, P = 0.020), ApoB/ApoA ratio (r = 0.233, P = 0.041), and carotid intima-media thickness (r = 0.236, P = 0.041). After multiple linear regression, only male gender (P = 0.046) and hsCRP (P = 0.012) remained independently associated with the Gensini score. In this high-risk population, male gender and high levels of hsCRP, two variables that can be easily obtained, were associated with more extensive coronary disease, identifying patients with the highest potential of developing new coronary events.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 34 条
[1]   Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the multi-ethnic study of atherosclerosis (MESA) [J].
Bertoni, Alain G. ;
Wong, Nathan D. ;
Shea, Steven ;
Ma, Shuangge ;
Liu, Kiang ;
Preethi, Srikanthan ;
Jacobs, David R. ;
Wu, Colin ;
Saad, Mohammed F. ;
Szklo, Moyses .
DIABETES CARE, 2007, 30 (11) :2951-2956
[2]   Carotid atherosclerosis and coronary heart disease in the metabolic syndrome - Prospective data from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2003, 26 (04) :1251-1257
[3]   Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality - The cardiovascular health study [J].
Cao, Jie J. ;
Arnold, Alice M. ;
Manolio, Teri A. ;
Polak, Joseph F. ;
Psaty, Bruce M. ;
Hirsch, Calvin H. ;
Kuller, Lewis H. ;
Cushman, Mary .
CIRCULATION, 2007, 116 (01) :32-38
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study [J].
Deedwania, Prakash ;
Barter, Philip ;
Carmena, Rafael ;
Fruchart, Jean-Charles ;
Grundy, Scott M. ;
Haffner, Steven ;
Kastelein, John J. P. ;
LaRosa, John C. ;
Schachner, Holly ;
Shepherd, James ;
Waters, David D. .
LANCET, 2006, 368 (9539) :919-928
[6]  
DUARTE ER, 2005, ARQ BRAS CARDIOL, V84, P122
[7]   Metabolic syndrome and progression of atherosclerosis among middle-aged US adults [J].
Fan, Amy Z. .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2006, 13 (01) :46-54
[8]   Detection of endothelial dysfunction with brachial artery ultrasound scanning [J].
Faulx, MD ;
Wright, AT ;
Hoit, BD .
AMERICAN HEART JOURNAL, 2003, 145 (06) :943-951
[9]   Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome [J].
Feinberg, Micha S. ;
Schwartz, Roseline ;
Tanne, David ;
Fisman, Enrique Z. ;
Hod, Hanoch ;
Zahger, Doron ;
Schwammethal, Ehud ;
Eldar, Michael ;
Behar, Solomon ;
Tenenbaum, Alexander .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05) :667-672
[10]   The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study [J].
Ford, ES .
ATHEROSCLEROSIS, 2004, 173 (02) :309-314